Accipiolx

Emergency Medicine Neurology Radiology

Regulatory Status Disclosed

Overview

MaxQ AI was a medical diagnostic artificial intelligence (AI) company that developed the Accipio platform, a suite of AI-powered software solutions for radiology. The Accipio platform, including AccipioIx, AccipioDx, and AccipioAx, was designed to provide decision support to healthcare professionals for the rapid assessment of non-contrast head CT scans to identify and prioritize cases of acute intracranial hemorrhage (ICH), stroke, and traumatic brain injury. The company’s solutions leveraged deep learning and machine vision technologies to analyze medical images and patient data, aiming to improve detection, accelerate workflow, and assist physicians in making faster, more accurate diagnoses in acute care settings.

It is important to note that MaxQ AI is a deadpooled company and stopped commercial operations in January 2022.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered intracranial hemorrhage (ICH) detection and prioritization
  • Workflow prioritization system (Accipio Ix)
  • Slice-level annotation and preview with SliceMap (Accipio Ax)
  • Automated analysis of non-contrast head CT images
  • Integration with PACS systems and CT scanners (DICOM standard)
  • Designed for rapid assessment of stroke, traumatic brain injury, and ICH
  • Augmented intelligence for physicians
  • Real-time intelligent orchestration (MaxQ Xpress)
  • Deep learning and machine vision technologies
  • Compatibility with major CT OEMs

Use Cases

  • Prioritizing suspected ICH cases in emergency rooms
  • Aiding in the diagnosis of stroke and traumatic brain injury
  • Enhancing clinical workflow in radiology departments
  • Providing decision support for neuroradiology teams
  • Rapid assessment in acute care settings for brain bleeds
  • Reducing missed intracranial hemorrhage detections

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCan be natively integrated into CT and PACS systems using DICOM, installed both on-premise and cloud-capable. It can be deployed into any existing PACS system "in a few hours."
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2020-08-07K201310 510(k)Accipiolx

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Accipiolx

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Accipiolx.

Loading videos...

View all on YouTube

Frequently Asked Questions

Accipiolx offers seamless API integration with most major EHR platforms, typically requiring 2-4 weeks for full implementation. Comprehensive online and in-person training modules are provided to ensure rapid staff adoption and proficiency.
Accipiolx is certified compliant with HIPAA and GDPR standards, employing advanced encryption and de-identification protocols for all patient data. Regular third-party audits verify our adherence to the highest data security and privacy regulations.
Accipiolx distinguishes itself through its proprietary AI-driven predictive analytics, offering highly personalized patient risk stratification and treatment recommendations. It also features a unique real-time feedback loop that continuously refines its algorithms based on clinical outcomes.
Accipiolx operates on a transparent tiered subscription model based on the number of active users or patient encounters, with no hidden fees. Volume discounts are available for larger institutions, and a detailed quote can be provided after an initial needs assessment.
While highly robust, Accipiolx's current algorithms may have reduced accuracy in extremely rare disease presentations or in populations with highly atypical genetic profiles not well-represented in its training data. We continuously update our models to address these edge cases.
Accipiolx is designed to integrate unobtrusively into existing workflows, providing context-sensitive alerts only for high-priority clinical scenarios. Its intelligent filtering system significantly reduces alert fatigue by prioritizing actionable insights over generic warnings.
Accipiolx's knowledge base is updated quarterly with the latest evidence-based medicine, clinical guidelines, and drug information. We actively solicit and incorporate user feedback through dedicated channels to continuously improve the system's utility and accuracy.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.